FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide (Q84553182)
Jump to navigation
Jump to search
scientific article published on 13 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide |
scientific article published on 13 July 2011 |
Statements
FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide (English)
Carl Weidinger
Kerstin Krause
Kathrin Mueller
Antje Klagge